Natera
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
NTRA Key Statistics
Stock Snapshot
As of today, Natera(NTRA) shares are valued at $193.37. The company's market cap stands at 27.41B, with a P/E ratio of -118.35.
On 2026-05-11, Natera(NTRA) stock moved within a range of $190.57 to $198.00. With shares now at $193.37, the stock is trading +1.5% above its intraday low and -2.3% below the session's peak.
Trading volume for Natera(NTRA) stock has reached 133.79K, versus its average volume of 1.76M.
Over the past 52 weeks, Natera(NTRA) stock has traded between a high of $256.36 and a low of $131.81.
Over the past 52 weeks, Natera(NTRA) stock has traded between a high of $256.36 and a low of $131.81.
NTRA News
Natera (NTRA) just reported record Q1 2026 results, with revenue of US$696.64 million and more than one million tests processed. A wider net loss and raised ful...
Natera (NasdaqGS:NTRA) raised its full-year 2026 revenue and gross margin guidance after reporting record test volumes. The company cited accelerating growth i...
Natera Inc. ((NTRA)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and powerfu...
Analyst ratings
90%
of 20 ratingsMore NTRA News
Evercore ISI raised the firm’s price target on Natera (NTRA) to $270 from $250 and keeps an Outperform rating on the shares. Unlock hedge fund-level data and p...
TD Cowen analyst Daniel Brennan maintained a Buy rating on Natera yesterday and set a price target of $280.00. Claim 55% Off TipRanks Unlock hedge fund-level da...
Image source: The Motley Fool. Thursday, May 7, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Steve Chapman President, Clinical Diagnostics...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.